🔎 Trials Near Me

Gara Jalqabaatti › Myositis › North Carolina

Qorannoo klinikaalii Myositis North Carolina keessatti

Qorannoo 12 Myositis f North Carolina keessatti hirmaatuu jiru.

Magaalota North Carolina keessatti

Takkalaa qorannoo (Ingiliffa)

Environmental Risk Factors for the Anti-synthetase Syndrome

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT01276470

Adult and Juvenile Myositis

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
Umuriin 2 hanga 100 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT00017914

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

  • University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill
  • Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
Namoota walitti qabaa jiraSadarkaa 2/3
Umuriin 6 hanga 75 · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06154252

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • Atrium Health Rheumatology-Southpark, Charlotte
  • Duke University Medical Center, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 10-Ful-2026 · NCT07085104

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

  • University of North Carolina TraCS Institute - CTRC, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 70 · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT06925542

Descartes-08 in Autoantibody Myositis

  • University of North Carolina, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07391605

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

  • Nkarta Investigational Site, Charlotte
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT06733935

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Charlotte, Charlotte
  • Artiva Investigational Site Statesville, Statesville
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06991114

A Study of AZD0120 in Autoimmune Diseases

  • Research Site, Chapel Hill
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT07295847

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

  • Duke University, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT07115745

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

  • Duke University Health System, Durham
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 12 hanga 70 · Saalaa hunda · Haaromfame 22-Cam-2026 · NCT06308978

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.